|
HUE039169T2
(hu)
*
|
2007-03-23 |
2018-12-28 |
Wyeth Llc |
Rövidített tisztítási eljárás Streptococcus pneumoniae tok-poliszacharidok elõállítására
|
|
GB0818453D0
(en)
*
|
2008-10-08 |
2008-11-12 |
Novartis Ag |
Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
|
|
PT2349520T
(pt)
*
|
2008-10-27 |
2016-08-16 |
Glaxosmithkline Biologicals Sa |
Método de purificação para hidrato de carbono de estreptococos grupo a
|
|
EP2385981B1
(en)
*
|
2008-12-18 |
2019-09-04 |
Wyeth LLC |
Method for controlling streptococcus pneumoniae polysaccharide molecular weight using carbon
|
|
WO2010080486A2
(en)
*
|
2008-12-18 |
2010-07-15 |
Wyeth Llc |
Method for controlling streptococcus pneumoniae serotype 19a polysaccharide molecular weight
|
|
DK2424562T3
(en)
|
2009-04-30 |
2015-12-07 |
Coley Pharm Group Inc |
Pneumococcal vaccine and uses thereof
|
|
WO2011041003A2
(en)
|
2009-06-22 |
2011-04-07 |
Wyeth Llc |
Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
|
|
AU2010264538B2
(en)
|
2009-06-22 |
2013-10-03 |
Wyeth Llc |
Immunogenic compositions of Staphylococcus aureus antigens
|
|
TW201136603A
(en)
*
|
2010-02-09 |
2011-11-01 |
Merck Sharp & Amp Dohme Corp |
15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
|
|
US20110262989A1
(en)
|
2010-04-21 |
2011-10-27 |
Nanomr, Inc. |
Isolating a target analyte from a body fluid
|
|
US8841104B2
(en)
|
2010-04-21 |
2014-09-23 |
Nanomr, Inc. |
Methods for isolating a target analyte from a heterogeneous sample
|
|
US9476812B2
(en)
|
2010-04-21 |
2016-10-25 |
Dna Electronics, Inc. |
Methods for isolating a target analyte from a heterogeneous sample
|
|
WO2011145108A2
(en)
*
|
2010-05-15 |
2011-11-24 |
Serum Institute Of India Ltd. |
Purification of capsular polysaccharides
|
|
BR112013024322B1
(pt)
*
|
2011-03-22 |
2020-04-22 |
Serum Inst India Ltd |
processo para preparação de polissacarídeos
|
|
CN102660601B
(zh)
*
|
2012-04-17 |
2015-10-28 |
江苏康泰生物医学技术有限公司 |
快速纯化细菌荚膜多糖的方法
|
|
CN102660603B
(zh)
*
|
2012-04-17 |
2015-03-25 |
江苏康泰生物医学技术有限公司 |
一种快速纯化细菌荚膜多糖的方法
|
|
CN102660602B
(zh)
*
|
2012-04-17 |
2015-03-25 |
江苏康泰生物医学技术有限公司 |
快速纯化细菌荚膜多糖的方法
|
|
US9650411B2
(en)
*
|
2012-08-07 |
2017-05-16 |
Kyowa Hakko Kirin Co., Ltd. |
Method of purifying protein
|
|
CA2884241C
(en)
*
|
2012-09-07 |
2018-11-20 |
Sk Chemicals Co., Ltd. |
Production method for capsular polysaccharide having pneumococcal serotype
|
|
CN104582718B
(zh)
|
2012-10-03 |
2017-10-24 |
诺华股份有限公司 |
免疫原性组合物
|
|
US9995742B2
(en)
|
2012-12-19 |
2018-06-12 |
Dnae Group Holdings Limited |
Sample entry
|
|
US9434940B2
(en)
|
2012-12-19 |
2016-09-06 |
Dna Electronics, Inc. |
Methods for universal target capture
|
|
US9599610B2
(en)
|
2012-12-19 |
2017-03-21 |
Dnae Group Holdings Limited |
Target capture system
|
|
US9551704B2
(en)
|
2012-12-19 |
2017-01-24 |
Dna Electronics, Inc. |
Target detection
|
|
US9804069B2
(en)
|
2012-12-19 |
2017-10-31 |
Dnae Group Holdings Limited |
Methods for degrading nucleic acid
|
|
US10000557B2
(en)
|
2012-12-19 |
2018-06-19 |
Dnae Group Holdings Limited |
Methods for raising antibodies
|
|
CA2912765C
(en)
|
2013-07-12 |
2018-05-01 |
Emd Millipore Corporation |
A method of determining virus removal from a sample containing a target protein using activated carbon
|
|
WO2015095868A1
(en)
|
2013-12-20 |
2015-06-25 |
Wake Forest University Health Sciences |
Methods and compositions for increasing protective antibody levels induced by pneumococcal polysaccharide vaccines
|
|
FI3583947T3
(fi)
*
|
2014-01-21 |
2023-10-12 |
Pfizer |
Streptococcus pneumoniaen kapselipolysakkaridit ja niiden konjugaatit
|
|
IL312327B2
(en)
|
2014-01-21 |
2026-02-01 |
Pfizer |
Immunogenic preparations comprising conjugated capsular saccharide antigens and their uses
|
|
US11160855B2
(en)
|
2014-01-21 |
2021-11-02 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
BR112016015835B1
(pt)
|
2014-01-21 |
2023-12-26 |
Pfizer Inc |
Processo de preparação de conjugados compreendendo polissacarídeos capsulares de streptococcus pneumoniae
|
|
US9107906B1
(en)
|
2014-10-28 |
2015-08-18 |
Adma Biologics, Inc. |
Compositions and methods for the treatment of immunodeficiency
|
|
PL3244917T3
(pl)
|
2015-01-15 |
2023-07-17 |
Pfizer Inc. |
Kompozycje immunogenne do zastosowania w szczepionkach przeciwko pneumokokom
|
|
KR102143534B1
(ko)
*
|
2015-05-04 |
2020-08-12 |
화이자 인코포레이티드 |
B군 스트렙토코쿠스 폴리사카라이드-단백질 접합체, 접합체를 생산하는 방법, 접합체를 포함하는 면역원성 조성물, 및 그의 용도
|
|
HK1249149A1
(zh)
*
|
2015-06-18 |
2018-10-26 |
一般财团法人阪大微生物病研究会 |
肺炎球菌补体依赖性杀菌能力测量方法
|
|
KR20250058066A
(ko)
|
2015-07-21 |
2025-04-29 |
화이자 인코포레이티드 |
접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도
|
|
CN105131139B
(zh)
*
|
2015-07-31 |
2018-02-13 |
兰州生物制品研究所有限责任公司 |
一种肺炎链球菌荚膜多糖的纯化方法
|
|
US10786561B2
(en)
|
2015-11-20 |
2020-09-29 |
Pfizer Inc. |
Immunogenic compositions for use in pneumococcal vaccines
|
|
US11224652B2
(en)
|
2016-08-05 |
2022-01-18 |
Sanofi Pasteur Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
EP3493837B1
(en)
|
2016-08-05 |
2022-08-31 |
Sanofi Pasteur, Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
US10751402B2
(en)
|
2016-11-09 |
2020-08-25 |
Pfizer Inc. |
Immunogenic compositions and uses thereof
|
|
IL267709B2
(en)
|
2016-12-30 |
2025-04-01 |
Vaxcyte Inc |
Polypeptide-antigen conjugates with unnatural amino acids
|
|
US11951165B2
(en)
|
2016-12-30 |
2024-04-09 |
Vaxcyte, Inc. |
Conjugated vaccine carrier proteins
|
|
BR112019014833A2
(pt)
|
2017-01-20 |
2020-04-14 |
Pfizer |
composições imunogênicas para uso em vacinas pneumococais
|
|
WO2018144439A1
(en)
|
2017-01-31 |
2018-08-09 |
Merck Sharp & Dohme Corp. |
Methods for making polysaccharide-protein conjugates
|
|
CN110225757A
(zh)
|
2017-01-31 |
2019-09-10 |
默沙东公司 |
由肺炎链球菌血清型19f生产荚膜多糖蛋白缀合物的方法
|
|
CN110392690B
(zh)
|
2017-02-24 |
2024-01-30 |
默沙东有限责任公司 |
肺炎球菌缀合物疫苗制剂
|
|
JP7680185B2
(ja)
|
2017-02-24 |
2025-05-20 |
メルク・シャープ・アンド・ドーム・エルエルシー |
肺炎連鎖球菌多糖－タンパク質コンジュゲートの免疫原性の増強
|
|
US10259865B2
(en)
|
2017-03-15 |
2019-04-16 |
Adma Biologics, Inc. |
Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
|
|
US10729763B2
(en)
|
2017-06-10 |
2020-08-04 |
Inventprise, Llc |
Mixtures of polysaccharide-protein pegylated compounds
|
|
MX2019014829A
(es)
|
2017-06-10 |
2020-08-17 |
Inventprise Llc |
Vacunas de conjugado multivalente con polisacáridos de conjugado bivalente o multivalente que proporcionan inmunogenicidad y avidez mejoradas.
|
|
US10435433B2
(en)
|
2017-07-05 |
2019-10-08 |
Inventprise, Llc |
Polysaccharide purification for vaccine production using lytic enzymes, tangential flow filtration, and multimode chromatography
|
|
US10702596B2
(en)
|
2017-07-05 |
2020-07-07 |
Inventprise, Llc |
Polysaccharide purification for vaccine production using lytic enzymes, tangential flow filtration, and multimode chromatography
|
|
CN111065387B
(zh)
|
2017-09-07 |
2023-08-25 |
默沙东有限责任公司 |
肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
|
|
HUE068482T2
(hu)
|
2017-09-07 |
2025-01-28 |
Merck Sharp & Dohme Llc |
Pneumococcus-poliszacharidok és azok felhasználása immunogén poliszacharid-hordozóprotein konjugátumokban
|
|
US11395849B2
(en)
|
2017-09-07 |
2022-07-26 |
Merck Sharp & Dohme Llc |
Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
|
|
CN107936128B
(zh)
*
|
2017-11-22 |
2020-07-03 |
成都欧林生物科技股份有限公司 |
一种简便有效的细菌疫苗纯化方法
|
|
EP3720483B1
(en)
|
2017-12-06 |
2025-11-19 |
Merck Sharp & Dohme LLC |
Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
|
|
WO2019152921A1
(en)
|
2018-02-05 |
2019-08-08 |
Sanofi Pasteur Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
BR112020015696A2
(pt)
|
2018-02-05 |
2020-12-08 |
Sanofi Pasteur, Inc. |
Composição de conjugado polissacarídeo-proteína pneumocócico multivalente
|
|
WO2019212842A1
(en)
|
2018-04-30 |
2019-11-07 |
Merck Sharp & Dohme Corp. |
Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres
|
|
WO2019212846A1
(en)
|
2018-04-30 |
2019-11-07 |
Merck Sharp & Dohme Corp. |
Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates
|
|
JP7397000B2
(ja)
|
2018-04-30 |
2023-12-12 |
メルク・シャープ・アンド・ドーム・エルエルシー |
凍結乾燥変異ジフテリア毒素のジメチルスルホキシド中均一溶液を提供する方法
|
|
EP4483896A3
(en)
|
2018-07-04 |
2025-04-02 |
Vaxcyte, Inc. |
Improvements in immunogenic conjugates
|
|
WO2020010000A1
(en)
|
2018-07-04 |
2020-01-09 |
Sutrovax, Inc. |
Improved methods for the preparation of immunogenic conjugates
|
|
WO2020010016A1
(en)
|
2018-07-04 |
2020-01-09 |
Sutrovax, Inc. |
Self-adjuvanted immunogenic conjugates
|
|
WO2020016322A1
(en)
*
|
2018-07-19 |
2020-01-23 |
Glaxosmithkline Biologicals Sa |
Processes for preparing dried polysaccharides
|
|
US20220016229A1
(en)
|
2018-12-12 |
2022-01-20 |
Pfizer Inc. |
Immunogenic Multiple Hetero-Antigen Polysaccharide-Protein Conjugates and uses thereof
|
|
EP3897705A2
(en)
|
2018-12-19 |
2021-10-27 |
Merck Sharp & Dohme Corp. |
Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
|
|
JP7239509B6
(ja)
*
|
2019-02-22 |
2023-03-28 |
ファイザー・インク |
細菌多糖類を精製するための方法
|
|
US20220184199A1
(en)
|
2019-04-10 |
2022-06-16 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
|
|
JP2022542316A
(ja)
|
2019-07-31 |
2022-09-30 |
サノフィ パスツール インコーポレイテッド |
多価肺炎球菌多糖体－タンパク質コンジュゲート組成物およびその使用方法
|
|
US12473379B2
(en)
*
|
2019-09-06 |
2025-11-18 |
Serum Institute Of India Private Limited |
Method for obtaining purified bacterial polysaccharides
|
|
CN115362177A
(zh)
*
|
2020-02-21 |
2022-11-18 |
辉瑞公司 |
糖类的纯化
|
|
US20230227487A1
(en)
*
|
2020-06-12 |
2023-07-20 |
Basf Se |
Improved demineralization of fermentation broths and purification of fine chemicals such as oligosaccharides
|
|
US12053515B2
(en)
|
2020-08-10 |
2024-08-06 |
Inventprise, Inc. |
Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24F
|
|
EP4203995A1
(en)
|
2020-08-26 |
2023-07-05 |
Pfizer Inc. |
Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
|
|
GB202016165D0
(en)
|
2020-10-12 |
2020-11-25 |
Optivalent Ltd |
Vaccine
|
|
US20230383324A1
(en)
|
2020-10-22 |
2023-11-30 |
Pfizer Inc. |
Methods for purifying bacterial polysaccharides
|
|
CA3200602A1
(en)
|
2020-11-04 |
2022-05-12 |
Pfizer Inc. |
Immunogenic compositions for use in pneumococcal vaccines
|
|
US20230405137A1
(en)
|
2020-11-10 |
2023-12-21 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
TW202245835A
(zh)
|
2021-02-04 |
2022-12-01 |
美商默沙東有限責任公司 |
用於肺炎球菌結合物疫苗之奈米乳化液佐劑組合物
|
|
CA3218544A1
(en)
|
2021-05-03 |
2022-11-10 |
Pfizer Inc. |
Vaccination against bacterial and betacoronavirus infections
|
|
WO2022234416A1
(en)
|
2021-05-03 |
2022-11-10 |
Pfizer Inc. |
Vaccination against pneumoccocal and covid-19 infections
|
|
CA3221075A1
(en)
|
2021-05-28 |
2022-12-01 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
JP7714690B2
(ja)
|
2021-05-28 |
2025-07-29 |
ファイザー・インク |
コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用
|
|
JP2025508749A
(ja)
|
2022-01-13 |
2025-04-10 |
ファイザー・インク |
コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用
|
|
GB2614916A
(en)
|
2022-01-25 |
2023-07-26 |
Optivalent Ltd |
Intradermal vaccine complement
|
|
WO2023161817A1
(en)
|
2022-02-25 |
2023-08-31 |
Pfizer Inc. |
Methods for incorporating azido groups in bacterial capsular polysaccharides
|
|
US20260130987A1
(en)
|
2022-10-19 |
2026-05-14 |
Pfizer Inc. |
Vaccination against pneumoccocal and covid-19 infections
|
|
WO2024110827A1
(en)
|
2022-11-21 |
2024-05-30 |
Pfizer Inc. |
Methods for preparing conjugated capsular saccharide antigens and uses thereof
|
|
EP4622665A2
(en)
|
2022-11-22 |
2025-10-01 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
CN120513083A
(zh)
|
2022-12-01 |
2025-08-19 |
辉瑞大药厂 |
肺炎链球菌缀合物疫苗制剂
|
|
WO2024166008A1
(en)
|
2023-02-10 |
2024-08-15 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
AU2024246082A1
(en)
|
2023-03-30 |
2025-10-16 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
PE20252779A1
(es)
|
2023-04-14 |
2025-12-22 |
Pfizer |
Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados y usos de estos
|
|
WO2024224266A1
(en)
|
2023-04-24 |
2024-10-31 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
PE20260294A1
(es)
|
2023-05-18 |
2026-02-10 |
Merck Sharp And Dohme Llc |
Compuestos y formulaciones adyuvantes utiles en vacunas neumococicas
|
|
CN121263203A
(zh)
|
2023-05-19 |
2026-01-02 |
葛兰素史克生物有限公司 |
诱导对呼吸道合胞病毒和肺炎链球菌感染的免疫反应的方法
|
|
TW202527906A
(zh)
|
2023-09-14 |
2025-07-16 |
美商輝瑞股份有限公司 |
包含經結合之肺炎鏈球菌莢膜醣抗原之佐劑化致免疫性組成物及其用途
|
|
WO2025133971A1
(en)
|
2023-12-23 |
2025-06-26 |
Pfizer Inc. |
Improved methods for producing bacterial capsular saccharide glycoconjugates
|
|
WO2025186705A2
(en)
|
2024-03-06 |
2025-09-12 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
WO2025219904A1
(en)
|
2024-04-19 |
2025-10-23 |
Pfizer Inc. |
Improved methods for producing glycoconjugates by reductive amination in aprotic solvent
|
|
WO2025219908A2
(en)
|
2024-04-19 |
2025-10-23 |
Pfizer Inc. |
Media and fermentation methods for polysaccharide production in bacterial cell culture
|
